Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 254

1.

[Coronary artery dissection following blunt chest trauma].

Seven E, Henningsen K, Abildgaard U.

Ugeskr Laeger. 2015 Mar 16;177(12). pii: V10140572. Danish.

PMID:
25786846
2.

Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.

Kristensen SL, Galløe AM, Thuesen L, Kelbæk H, Thayssen P, Havndrup O, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Jeppesen JL.

PLoS One. 2014 Nov 19;9(11):e113399. doi: 10.1371/journal.pone.0113399. eCollection 2014.

3.

Association between endovascular performance in a simulated setting and in the catheterization laboratory.

Räder SB, Abildgaard U, Jørgensen E, Bech B, Lönn L, Ringsted CV.

Simul Healthc. 2014 Aug;9(4):241-8. doi: 10.1097/SIH.0000000000000037.

PMID:
25090168
4.

Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review.

Abildgaard U, Heimdal K.

Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):117-23. doi: 10.1016/j.ejogrb.2012.09.026. Epub 2012 Oct 26. Review.

PMID:
23107053
5.

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.

Maeng M, Tilsted HH, Jensen LO, Kaltoft A, Kelbæk H, Abildgaard U, Villadsen AB, Krusell LR, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Thayssen P, Sørensen HT, Thuesen L, Lassen JF.

JACC Cardiovasc Interv. 2012 Aug;5(8):812-8. doi: 10.1016/j.jcin.2012.04.008.

6.
7.

Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).

Maeng M, Jensen LO, Tilsted HH, Kaltoft A, Kelbaek H, Abildgaard U, Villadsen A, Aarøe J, Thayssen P, Krusell LR, Christiansen EH, Bøtker HE, Kristensen SD, Ravkilde J, Madsen M, Sørensen HT, Rasmussen K, Thuesen L, Lassen JF.

Am J Cardiol. 2011 Nov 1;108(9):1232-7. doi: 10.1016/j.amjcard.2011.06.037. Epub 2011 Aug 23.

PMID:
21864817
8.

Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.

Pedersen S, Galatius S, Mogelvang R, Abildstrom SZ, Sorensen R, Galloe A, Abildgaard U, Hansen P, Davidsen U, Iversen A, Bech J, Madsen JK, Jensen JS.

J Invasive Cardiol. 2011 Aug;23(8):328-33.

9.

System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).

Nielsen PH, Terkelsen CJ, Nielsen TT, Thuesen L, Krusell LR, Thayssen P, Kelbaek H, Abildgaard U, Villadsen AB, Andersen HR, Maeng M; Danami-2 Investigators.

Am J Cardiol. 2011 Sep 15;108(6):776-81. doi: 10.1016/j.amjcard.2011.05.007. Epub 2011 Jul 15.

PMID:
21757183
10.

Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy.

Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U.

Thromb Res. 2011 Jun;127(6):540-6. doi: 10.1016/j.thromres.2011.02.017. Epub 2011 Mar 24.

PMID:
21435698
11.

Impact of abciximab in diabetic patients with acute coronary syndrome who undergo percutaneous coronary intervention: results from a high-volume, single-center registry.

Iversen AZ, Pedersen SH, Joens C, Mogelvang R, Galatius S, Galloe A, Abildgaard U, Hansen PR, Madsen JK, Jensen JS.

J Invasive Cardiol. 2011 Jan;23(1):21-6.

12.

Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial.

Iversen A, Abildgaard U, Galloe A, Hansen PR, Galatius S, Madsen JK, Engstroem T, Pedersen S, Jensen KS, Jensen JS.

J Interv Cardiol. 2011 Apr;24(2):105-11. doi: 10.1111/j.1540-8183.2010.00616.x. Epub 2010 Dec 22.

PMID:
21175845
13.

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.

Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group.

Lancet. 2010 Mar 27;375(9720):1090-9. doi: 10.1016/S0140-6736(10)60208-5. Epub 2010 Mar 16.

PMID:
20231034
14.

Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study.

Sørensen R, Abildstrom SZ, Weeke P, Fosbøl EL, Folke F, Hansen ML, Hansen PR, Madsen JK, Abildgaard U, Køber L, Poulsen HE, Torp-Pedersen C, Gislason GH.

BMC Cardiovasc Disord. 2010 Jan 29;10:6. doi: 10.1186/1471-2261-10-6.

15.

Long-term prognosis in an ST-segment elevation myocardial infarction population treated with routine primary percutaneous coronary intervention: from clinical trial to real-life experience.

Pedersen S, Galatius S, Mogelvang R, Davidsen U, Galloe A, Abildstrom SZ, Abildgaard U, Hansen PR, Bech J, Iversen A, Jorgensen E, Kelbaek H, Saunamaki K, Madsen JK, Jensen JS.

Circ Cardiovasc Interv. 2009 Oct;2(5):392-400. doi: 10.1161/CIRCINTERVENTIONS.108.845636. Epub 2009 Aug 18.

16.

Field triage reduces treatment delay and improves long-term clinical outcome in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Pedersen SH, Galatius S, Hansen PR, Mogelvang R, Abildstrom SZ, Sørensen R, Davidsen U, Galloe A, Abildgaard U, Iversen A, Bech J, Madsen JK, Jensen JS.

J Am Coll Cardiol. 2009 Dec 8;54(24):2296-302. doi: 10.1016/j.jacc.2009.06.056.

17.

The HELLP syndrome: clinical issues and management. A Review.

Haram K, Svendsen E, Abildgaard U.

BMC Pregnancy Childbirth. 2009 Feb 26;9:8. doi: 10.1186/1471-2393-9-8. Review.

18.

Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.

Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A.

Thromb Res. 2009 Jul;124(3):262-7. doi: 10.1016/j.thromres.2008.12.005. Epub 2009 Jan 21.

PMID:
19162303
19.

Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudy.

Busk M, Kristensen SD, Rasmussen K, Kelbaek H, Thayssen P, Madsen JK, Abildgaard U, Krusell LR, Mortensen LS, Thuesen L, Andersen HR, Nielsen TT; DANAMI-2 Investigators.

Cardiology. 2009;113(1):72-80. doi: 10.1159/000171069. Epub 2008 Nov 13.

PMID:
19005253
20.

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.

Galløe AM, Thuesen L, Kelbaek H, Thayssen P, Rasmussen K, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Ravkilde J, Engstrøm T, Jensen JS, Andersen HR, Bøtker HE, Galatius S, Kristensen SD, Madsen JK, Krusell LR, Abildstrøm SZ, Stephansen GB, Lassen JF; SORT OUT II Investigators.

JAMA. 2008 Jan 30;299(4):409-16. doi: 10.1001/jama.299.4.409.

PMID:
18230778
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk